Logo image of BN.CA

BROOKFIELD CORP (BN.CA) Stock Fundamental Analysis

TSX:BN - Toronto Stock Exchange - CA11271J1075 - Common Stock - Currency: CAD

79.82  -0.57 (-0.71%)

Fundamental Rating

3

Overall BN gets a fundamental rating of 3 out of 10. We evaluated BN against 82 industry peers in the Capital Markets industry. BN has a bad profitability rating. Also its financial health evaluation is rather negative. BN is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

BN had positive earnings in the past year.
In the past year BN had a positive cash flow from operations.
Of the past 5 years BN 4 years were profitable.
In the past 5 years BN always reported a positive cash flow from operatings.
BN.CA Yearly Net Income VS EBIT VS OCF VS FCFBN.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B 20B

1.2 Ratios

BN has a worse Return On Assets (0.09%) than 68.29% of its industry peers.
The Return On Equity of BN (0.99%) is worse than 65.85% of its industry peers.
With a Return On Invested Capital value of 3.48%, BN perfoms like the industry average, outperforming 41.46% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for BN is below the industry average of 8.43%.
Industry RankSector Rank
ROA 0.09%
ROE 0.99%
ROIC 3.48%
ROA(3y)0.24%
ROA(5y)0.32%
ROE(3y)2.5%
ROE(5y)2.99%
ROIC(3y)3.69%
ROIC(5y)3.45%
BN.CA Yearly ROA, ROE, ROICBN.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8 10

1.3 Margins

With a Profit Margin value of 0.55%, BN is not doing good in the industry: 63.41% of the companies in the same industry are doing better.
BN's Profit Margin has declined in the last couple of years.
BN's Operating Margin of 24.95% is in line compared to the rest of the industry. BN outperforms 47.56% of its industry peers.
In the last couple of years the Operating Margin of BN has grown nicely.
BN's Gross Margin of 35.04% is on the low side compared to the rest of the industry. BN is outperformed by 62.20% of its industry peers.
In the last couple of years the Gross Margin of BN has grown nicely.
Industry RankSector Rank
OM 24.95%
PM (TTM) 0.55%
GM 35.04%
OM growth 3Y4.81%
OM growth 5Y5.87%
PM growth 3Y-52.22%
PM growth 5Y-32.46%
GM growth 3Y8.55%
GM growth 5Y6.54%
BN.CA Yearly Profit, Operating, Gross MarginsBN.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

1

2. Health

2.1 Basic Checks

Compared to 1 year ago, BN has less shares outstanding
BN has about the same amout of shares outstanding than it did 5 years ago.
Compared to 1 year ago, BN has a worse debt to assets ratio.
BN.CA Yearly Shares OutstandingBN.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
BN.CA Yearly Total Debt VS Total AssetsBN.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100B 200B 300B 400B

2.2 Solvency

A Debt/Equity ratio of 5.43 is on the high side and indicates that BN has dependencies on debt financing.
BN has a worse Debt to Equity ratio (5.43) than 86.59% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.43
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
BN.CA Yearly LT Debt VS Equity VS FCFBN.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50B 100B 150B

2.3 Liquidity

BN has a Current Ratio of 1.11. This is a normal value and indicates that BN is financially healthy and should not expect problems in meeting its short term obligations.
BN has a Current ratio of 1.11. This is in the lower half of the industry: BN underperforms 73.17% of its industry peers.
A Quick Ratio of 0.96 indicates that BN may have some problems paying its short term obligations.
BN's Quick ratio of 0.96 is on the low side compared to the rest of the industry. BN is outperformed by 74.39% of its industry peers.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 0.96
BN.CA Yearly Current Assets VS Current LiabilitesBN.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 35.71% over the past year.
BN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 18.12% yearly.
Looking at the last year, BN shows a very negative growth in Revenue. The Revenue has decreased by -15.17% in the last year.
BN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.86% yearly.
EPS 1Y (TTM)35.71%
EPS 3Y-49.52%
EPS 5Y18.12%
EPS Q2Q%27.27%
Revenue 1Y (TTM)-15.17%
Revenue growth 3Y4.33%
Revenue growth 5Y4.86%
Sales Q2Q%1284.57%

3.2 Future

Based on estimates for the next years, BN will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.86% on average per year.
The Revenue is expected to grow by 19.06% on average over the next years. This is quite good.
EPS Next Y-0.17%
EPS Next 2Y9.46%
EPS Next 3Y11.86%
EPS Next 5YN/A
Revenue Next Year23.4%
Revenue Next 2Y17.85%
Revenue Next 3Y19.06%
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BN.CA Yearly Revenue VS EstimatesBN.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20B 40B 60B 80B
BN.CA Yearly EPS VS EstimatesBN.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 2 3 4 5

3

4. Valuation

4.1 Price/Earnings Ratio

BN is valuated correctly with a Price/Earnings ratio of 13.81.
The rest of the industry has a similar Price/Earnings ratio as BN.
Compared to an average S&P500 Price/Earnings ratio of 26.20, BN is valued a bit cheaper.
BN is valuated correctly with a Price/Forward Earnings ratio of 12.14.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BN indicates a somewhat cheap valuation: BN is cheaper than 64.63% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.13, BN is valued a bit cheaper.
Industry RankSector Rank
PE 13.81
Fwd PE 12.14
BN.CA Price Earnings VS Forward Price EarningsBN.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

BN's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.97
BN.CA Per share dataBN.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.76
EPS Next 2Y9.46%
EPS Next 3Y11.86%

2

5. Dividend

5.1 Amount

BN has a yearly dividend return of 0.63%, which is pretty low.
Compared to an average industry Dividend Yield of 3.19, BN has a dividend in line with its industry peers.
With a Dividend Yield of 0.63, BN pays less dividend than the S&P500 average, which is at 2.40.
Industry RankSector Rank
Dividend Yield 0.63%

5.2 History

The dividend of BN decreases each year by -3.57%.
BN has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of BN decreased recently.
Dividend Growth(5Y)-3.57%
Div Incr Years1
Div Non Decr Years1
BN.CA Yearly Dividends per shareBN.CA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

151.35% of the earnings are spent on dividend by BN. This is not a sustainable payout ratio.
DP151.35%
EPS Next 2Y9.46%
EPS Next 3Y11.86%
BN.CA Yearly Income VS Free CF VS DividendBN.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5B -10B
BN.CA Dividend Payout.BN.CA Dividend Payout, showing the Payout Ratio.BN.CA Dividend Payout.PayoutRetained Earnings

BROOKFIELD CORP

TSX:BN (5/28/2025, 7:00:00 PM)

79.82

-0.57 (-0.71%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)05-08 2025-05-08/bmo
Earnings (Next)08-06 2025-08-06/bmo
Inst Owners56.84%
Inst Owner ChangeN/A
Ins Owners10.91%
Ins Owner ChangeN/A
Market Cap131.51B
Analysts76.67
Price Target90.36 (13.2%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.63%
Yearly Dividend0.61
Dividend Growth(5Y)-3.57%
DP151.35%
Div Incr Years1
Div Non Decr Years1
Ex-Date06-13 2025-06-13 (0.09)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.97%
Min EPS beat(2)6.19%
Max EPS beat(2)11.75%
EPS beat(4)3
Avg EPS beat(4)21.57%
Min EPS beat(4)-0.3%
Max EPS beat(4)68.65%
EPS beat(8)7
Avg EPS beat(8)14.69%
EPS beat(12)9
Avg EPS beat(12)-3.55%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1228.35%
Min Revenue beat(2)1136.66%
Max Revenue beat(2)1320.03%
Revenue beat(4)4
Avg Revenue beat(4)1410.47%
Min Revenue beat(4)1136.66%
Max Revenue beat(4)1712.11%
Revenue beat(8)8
Avg Revenue beat(8)707.05%
Revenue beat(12)12
Avg Revenue beat(12)490.56%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-9.53%
PT rev (3m)-5.67%
EPS NQ rev (1m)-1.06%
EPS NQ rev (3m)-5.34%
EPS NY rev (1m)0.1%
EPS NY rev (3m)-0.62%
Revenue NQ rev (1m)-2.04%
Revenue NQ rev (3m)-94.22%
Revenue NY rev (1m)0.55%
Revenue NY rev (3m)-1%
Valuation
Industry RankSector Rank
PE 13.81
Fwd PE 12.14
P/S 1.17
P/FCF N/A
P/OCF 10.86
P/B 2.1
P/tB N/A
EV/EBITDA 10.97
EPS(TTM)5.78
EY7.24%
EPS(NY)6.58
Fwd EY8.24%
FCF(TTM)-11.95
FCFYN/A
OCF(TTM)7.35
OCFY9.21%
SpS68.02
BVpS37.99
TBVpS-24.32
PEG (NY)N/A
PEG (5Y)0.76
Profitability
Industry RankSector Rank
ROA 0.09%
ROE 0.99%
ROCE 4.67%
ROIC 3.48%
ROICexc 3.58%
ROICexgc 4.35%
OM 24.95%
PM (TTM) 0.55%
GM 35.04%
FCFM N/A
ROA(3y)0.24%
ROA(5y)0.32%
ROE(3y)2.5%
ROE(5y)2.99%
ROIC(3y)3.69%
ROIC(5y)3.45%
ROICexc(3y)3.83%
ROICexc(5y)3.59%
ROICexgc(3y)4.77%
ROICexgc(5y)4.39%
ROCE(3y)4.96%
ROCE(5y)4.64%
ROICexcg growth 3Y2.5%
ROICexcg growth 5Y4.8%
ROICexc growth 3Y1.58%
ROICexc growth 5Y3.93%
OM growth 3Y4.81%
OM growth 5Y5.87%
PM growth 3Y-52.22%
PM growth 5Y-32.46%
GM growth 3Y8.55%
GM growth 5Y6.54%
F-Score6
Asset Turnover0.16
Health
Industry RankSector Rank
Debt/Equity 5.43
Debt/FCF N/A
Debt/EBITDA 8.21
Cap/Depr 236.74%
Cap/Sales 28.38%
Interest Coverage 250
Cash Conversion 29.26%
Profit Quality N/A
Current Ratio 1.11
Quick Ratio 0.96
Altman-Z N/A
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)209.51%
Cap/Depr(5y)213.66%
Cap/Sales(3y)20.38%
Cap/Sales(5y)19.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)35.71%
EPS 3Y-49.52%
EPS 5Y18.12%
EPS Q2Q%27.27%
EPS Next Y-0.17%
EPS Next 2Y9.46%
EPS Next 3Y11.86%
EPS Next 5YN/A
Revenue 1Y (TTM)-15.17%
Revenue growth 3Y4.33%
Revenue growth 5Y4.86%
Sales Q2Q%1284.57%
Revenue Next Year23.4%
Revenue Next 2Y17.85%
Revenue Next 3Y19.06%
Revenue Next 5YN/A
EBIT growth 1Y-4.56%
EBIT growth 3Y9.35%
EBIT growth 5Y11.02%
EBIT Next Year486.05%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-69.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-8.13%
OCF growth 3Y-1.38%
OCF growth 5Y3.07%